DIACOMIT® is to be used in patients with a rare type of epilepsy called Dravet syndrome or ‘Severe Myoclonic Epilepsy in Infancy’ (SMEI).

DIACOMIT® is to be used as an add-on therapy to clobazam and valproate (other anti-epileptic drugs) to treat generalised tonic-clonic seizures when these are not adequately controlled with Clobazam and Valproate.